The participants of the study, which involved 635 adolescents and 291 adults, were interviewed telephonically about long-term adverse events of special interest a year after receiving Covaxin, which ...
Amid growing concern over the new Covid variant Omicron, Hyderabad-based vaccine manufacturer Bharat Biotech's Covaxin on ...
In the United States, we have three vaccines approved or under emergency use authorization for COVID-19: the vaccines known as Moderna (mRNA-1273), Pfizer (BNT162b2), and Johnson & Johnson (Ad26COVS1) ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
April 2 (Reuters) - The World Health Organization said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the ...
The Indian Council of Medical Research (ICMR), the country’s apex body for formulation, coordination, and promotion of biomedical research, has distanced itself from the ‘poorly designed study’ of the ...
The World Health Organization (WHO) has confirmed it has suspended the supply of Covaxin, produced by city-based Bharat Biotech, through UN procurement agencies and recommending to countries that ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The Indian-made COVID-19 vaccine Covaxin strongly protected New Delhi healthcare workers against ...
Bharat Biotech International Ltd on Friday said its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in children and adolescents of 2-18 years age group in phase ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results